Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

High 'on treatment' platelet reactivity in the Intensive Care Unit

Trial Profile

High 'on treatment' platelet reactivity in the Intensive Care Unit

Phase of Trial: Phase III

Latest Information Update: 06 Mar 2019

At a glance

  • Drugs Aspirin (Primary) ; Aspirin (Primary) ; Clopidogrel (Primary) ; Prasugrel (Primary) ; Ticagrelor (Primary)
  • Indications Critical illness
  • Focus Pharmacodynamics
  • Acronyms HTPR-ICU
  • Most Recent Events

    • 08 Feb 2019 Planned number of patients changed from 248 to 262.
    • 31 Aug 2018 Biomarkers information updated
    • 01 Aug 2017 Results of patients treated with prasugrel 10 mg (n=23) published in the Thrombosis and Haemostasis.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top